Latest News & Features
Careers
Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences group | Shoosmiths adds team in London to expand brand-focused IP services. 7 January 2025
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/0ad7f7a0-ccfe-11ef-ac51-c1a78d881281-Ritter_Alexander_TBD_4x5(153478413.webp)
Careers
New partner brings technical background in computer science and more than a decade experience in patent litigation | Expertise in tech, engineering, chemical, and life sciences sectors. 7 January 2025
Americas
The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company’s proposed generic version of a key ALS drug. 2 January 2025
Americas
As part of a lifecycle IP strategy for a therapeutic product, it can be important to protect inventions arising during the clinical development of the product. 25 December 2024
Americas
In an incredibly competitive and complex landscape, intellectual property is a critical asset for pharmaceutical and biotech companies. 25 December 2024
Americas
Dispute stems from Amneal’s efforts to market generic version of Teva’s inhaler for treating asthma | Precedential decision could restrict how brand-name pharmaceutical companies use the Orange Book to extend market exclusivity. 24 December 2024
Americas
Massachusetts medical research company is awarded damages following a jury verdict that found a Japanese pharma had infringed on its patent | Patent relates to Duchenne muscular dystrophy treatment. 24 December 2024
Americas
The Unified Patent Court (UPC) opened for business in June 2023. In this session, we will look at how UPC litigation has been shaping up over the last year, including practical tips based on our experiences so far. 24 December 2024
Americas
In this session, Will James and Tim Harris will discuss their personal experiences litigating life sciences cases before the UPC. They will share their substantive and procedural insights, as well as strategic considerations and pitfalls to avoid. 24 December 2024
Americas
Long-recognised, unwritten jurisdictional norms have seen questions of validity and infringement of registered IP rights reserved to the courts of the country of registration. 22 December 2024